Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Nucleotides industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Nitrogenous base trends
2.1.4 Application trends
2.1.5 Technology trends
2.1.6 Product trends
Chapter 3 Nucleotides Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising demand for nucleotide-based therapeutics
3.2.1.2 Increased research in genomics and molecular biology
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with nucleotide synthesis
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.3.1 By nitrogenous base
3.3.2 By application
3.3.3 By technology
3.3.4 By product
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Nucleotides Market Estimates and Forecast, By Nitrogenous Base, 2018-2032 (USD Million)
5.1 Key trends, by nitrogenous base
5.2 Purine
5.3 Pyrimidine
Chapter 6 Nucleotides Market Estimates and Forecast, By Application, 2018-2032 (USD Million)
6.1 Key trends, by application
6.2 Diagnostics research
6.3 Pharmaceuticals
6.4 Other applications
Chapter 7 Nucleotides Market Estimates and Forecast, By Technology, 2018-2032 (USD Million)
7.1 Key trends, by technology
7.2 TaqMan allelic discrimination
7.3 SNP by pyrosequencing
7.4 Gene chips & microarrays
7.5 Other technologies
Chapter 8 Nucleotides Market Estimates and Forecast, By Product, 2018-2032 (USD Million)
8.1 Key trends, by product
8.2 Deoxynucleotides
8.3 Ribonucleotides
8.4 Labelled nucleotides
8.5 Dideoxy nucleotides
Chapter 9 Nucleotides Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Nanjing Bio Together Co., Ltd.
10.2 Agilent Technologies
10.3 F. Hoffmann-La Roche Ltd. (CustomBiotech)
10.4 CJ CHEILJEDANG CORP.
10.5 DAESANG
10.6 Jena Bioscience GmbH
10.7 MEIHUA HOLDINGS GROUP CO. LTD
10.8 Promega Corporation
10.9 STAR LAKE BIOSCIENCE
10.10 Thermo Fisher Scientific Inc.
